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Abstract
MMP28 is constitutively expressed by epithelial cells in many tissues, including the respiratory epithelium in the
lung and keratinocytes in the skin. This constitutive expression suggests that MMP28 may serve a role in epithelial
cell homeostasis. In an effort to determine its function in epithelial cell biology, we generated cell lines expressing
wild-type or catalytically-inactive mutant MMP28 in two pulmonary epithelial cell lines, A549 and BEAS-2B. We
observed that over-expression of MMP28 provided protection against apoptosis induced by either serum-
deprivation or treatment with a protein kinase inhibitor, staurosporine. Furthermore, we observed increased
caspase-3/7 activity in influenza-infected lungs from Mmp28
-/- mice compared to wild-type mice, and this activity
localized to the airway epithelium but was not associated with a change in viral load. Thus, we have identified a
novel role of MMP28 in promoting epithelial cell survival in the lung.
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Background
The epithelium, which forms a continuous barrier to the
environment, is a first line defense against pathogens and
toxins [1], and this defense function is especially impor-
tant in lung. In addition to its barrier function, the airway
epithelium produces proteins that participate in host
defense, and through specialized mucociliary function,
performs vital functions in clearance of particles and
microbes [2,3].
Key effector proteins in the epithelial responses to injury
and infection are the members of the matrix metallopro-
teinase (MMP) family [4,5]. The epithelium is a source for
many MMPs, with most being induced upon challenge. In
the respiratory epithelium, induced MMPs have important
functions in regulating inflammatory responses and
wound repair [6-11]. In contrast to most epithelial MMPs
that are not expressed in unperturbed tissue, MMP28 (epi-
lysin) is constitutively produced by the abundant Clara
cells of the conducting airways, suggesting that this MMP
plays a role in respiratory epithelial cell homeostasis [12].
Studies of macrophage and neuron-derived MMP28
have demonstrated or suggested roles for this proteinase
in macrophage migration and neuronal myelination,
respectively [12-14]. However, epithelial-derived MMP28
likely performs different functions. In fact, we have found
that although respiratory epithelial cells are high expres-
sers of MMP28, its expression is down-regulated in
response to acute bacterial infection [12]. This pattern is
in contrast to the upregulation of MMP28 we reported
for infected macrophages [12].
To better understand the role of MMP28 in epithelial
cells, we created stable cell lines over-expressing either
wild-type or catalytically-inactive mutant MMP28 in
A549 and BEAS-2B cells, two human pulmonary epithe-
lial cell lines. In both cell lines, over-expression of wild-
type MMP28 conferred resistance to apoptosis. To
examine if this newly-identified in vitro function of
MMP-28 translated to an in vivo phenotype, we tested
the Mmp28
-/- mice for increased susceptibility to epithe-
lial cell apoptosis. Wild-type and Mmp28
-/- mice were
infected with influenza virus, and the whole lung was
homogenized for detection of caspase 3/7 activity. Addi-
tional samples were immunostained for active caspase 3.
We found that Mmp28
-/- mice had increased caspase 3
activity and this activity localized to the bronchial
e p i t h e l i u m .T o g e t h e r ,t h e s ed a t as u p p o r tar o l ef o r
epithelial-derived MMP28 in promoting cell survival.
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Generation of Stable Cell Lines
Plasmids containing wild-type or mutant human Mmp28
with a V5-HIS tag engineered to the carboxy terminus
were provided by Drs. Sara Illman and Jorma Keski-Oja,
University of Helsinki. The vector used to generate these
constructs was pEF1/V5-His (Invitrogen, Carlsbad, CA)
as described [15]. The mutant MMP28 construct con-
tains a single amino acid change (E to A at position 241)
within the catalytic domain, rendering it catalytically
inactive [15]. These constructs were transfected into
A549 (human lung adenocarcinoma cells) and BEAS-2B
(transformed bronchial epithelial cells) using lipofecta-
mine (Invitrogen). Cells were then selected with Geneti-
cin (G-418; Invitrogen), and clones expressing MMP28
were detected using immunofluorescent staining for the
V5 epitope.
Immunoblotting and immunofluorescence
Cells were lysed in RIPA buffer [50 mM Tris (pH 8), 150
mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, 0.1%
SDS] supplemented with Complete protease inhibitor
cocktail (Roche, Indianapolis, IN). After incubation on
ice, lysates were cleared of insoluble material by centrifu-
gation and proteins were separated by SDS-PAGE and
transferred to Immobilon PVDF membrane (Millipore,
Temecula, CA). Membranes were blocked with 5% milk
in TBS-T and then probed with anti-V5 HRP (1:2500;
Invitrogen). The membranes were then developed by
chemiluminescence using SuperSignal West Femto Sub-
strate (Pierce, Rockford, IL).
Immunofluorescence was performed on cells grown on
chamber slides and fixed in cold acetone and methanol
followed by a 1 hour incubation with FITC-conjugated
anti-V5 antibody (Invitrogen). Fluorescence was visua-
lized using an Olympus BX51 microscope.
Serum-Deprivation
MMP28 over-expressing cells (A549) were allowed to
adhere to collagen I coated-chamber slides (BD Bios-
ciences, San Jose, CA) in serum-free media (30,000 cells/
well). At serial time-points, images were obtained to enu-
merate adhered and spread cells. Cells were left in serum-
free media for up to 7 days. In separate experiments, cells
were allowed to adhere to untreated polystyrene chamber
slides in the presence of 10% serum. The following day,
the cells were washed in PBS and serum-free media was
added to the chambers. Each clone and experiment was
performed in duplicate.
Staurosporine Treatment
Cells were plated at a density of 3 × 10
4 cells/well in 96
well format (black plate with clear bottom), in DMEM
supplemented with 10% FBS media (Mediatech, Hern-
don, VA). The next day, the media was removed and
replaced with 50 μl of serum-free DMEM with increasing
concentrations of Staurosporine (0-2.0 μM), in triplicate
(Calbiochem, La Jolla, CA). After 18 hour incubation, an
equal volume of lysis buffer plus caspase 3/7 substrate,
(z-DEVD)2 -R110, was added to each well per manufac-
ture’s instructions (Cell Technology, Mountain View,
CA). The caspase 3/7 activity was determined at serial
times using excitation at 488 nm and emission at 530 nm
using a Synergy 4 Hybrid Multi-Mode Microplate Reader
(BioTek). In separate experiments, cell viability of staur-
osporine-treated cells was assessed by incubating the
cells with Alamar Blue (Resazurin; Invitrogen), which is
reduced by live cells to a fluorescent compound, Resoru-
fin (excitation: 570 nm).
Influenza Model
A/PR/8/34, a mouse-adapted H1N1 influenza, was ori-
ginally obtained from ATCC (ATCC# VR-777). Virus
was grown in embryonated chicken eggs. Briefly, 100 μL
diluted virus stock was injected into a shallow incision in
the eggshell. The incision was sealed with melted paraffin
and incubated at 37°C for 36-48 hours. The eggs were
subsequently incubated at 4°C for greater than 2 hours.
Allantoic fluid was isolated from infected eggs and
hemagglutinin activity was tested on chicken red blood
cells. Virus titers were calculated based on hemagglutinin
activity and on MDCK cells according to the method of
Reed and Muench [16]. C57BL/6 wild-type mice and
Mmp28
-/- mice were sedated with isofluorane and 100
PFU was delivered via oropharyngeal aspiration in 50 μL
sterile PBS. These protocols have been approved by the
Institutional Animal Care and Use Committee at the
University of Washington.
Three and five days after influenza infection, Mmp28
-/-
and wild-type mice (n = 4/group) were euthanized with
Beuthanasia-D (Shering-Plough, Union, NJ) and exsan-
guination. Uninfected Mmp28
-/- and wild-type control
( n=4 / g r o u p )m i c ew e r ea l s oe u t h a n i z e da tas e p a r a t e
time. In all mice, the left lung was removed and homoge-
nized in 1 ml of PBS. An aliquot was used for caspase 3/7
activity, and the remaining lung homogenate used for
RNA isolation with a commercially-available kit (Qiagen,
Valencia, CA). The right lung was inflated and embedded
in Tissue-Tek O.C.T. medium (Sakura Finetek, Torrance
CA), frozen in liquid nitrogen, and cut into 5 μm sections
for immunostaining. Additional wildtype and Mmp28
-/-
mice (n = 4-5/genotype/time-point) were infected for
collection of whole lung for RNA to assess for MMP
expression and viral replication at days 0, 3, 5, and 7. Day
0 mice were harvested immediately after instillation of
virus.
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For detection of whole lung caspase 3/7 activity, 50 μlo f
the whole lung homogenate was plated in duplicate on 96
well plates (Costar black plate with clear bottom, Corning
Inc.), and an equal volume of lysis buffer plus caspase 3/7
substrate, (z-DEVD)2 -R110, was added to each well per
manufacture’s instructions (Cell Technology). Starting at
15 min, the caspase activity was determined at serial times
using excitation at 488 nm and emission at 530 nm using
a Synergy 4 Hybrid Multi-Mode Microplate Reader
(BioTek).
Active Caspase 3 Immunostaining
Frozen lung sections (5 μm )w e r ef i x e di nc o l da c e t o n e
and methanol, washed with PBS and blocked with 5% goat
serum for 30 min. The lung was incubated with polyclonal
rabbit anti-human cleaved (active) caspase 3 (Biocare
Medical, Concord, CA) or rabbit IgG as control, diluted
1:100 in 1% goat serum for 60 min at room temperature,
followed by the secondary antibody, goat anti-rabbit IgG
conjugated to Alexa 568 (Invitrogen) at a concentration of
1:500. Fluorescence was visualized using an Olympus
BX51 microscope.
RT-PCR: Quantitative Reverse Transcription PCR (qRT-PCR)
Total RNA was isolated from whole lung using an RNeasy
Midi kit (Qiagen, Valencia, CA). The quantity and quality
of RNA were determined using a NanoDrop spectrophot-
ometer (NanoDrop Inc., Wilmington DE). cDNA was
synthesized from 5 μg total RNA with a High-Capacity
cDNA Archive kit (Applied Biosystems), and then treated
with RNaseH. Primers and probes (FAM dye-labeled) for
HPRT and influenza (5’ primer CATCCTGTTGTATAT-
GAGGCCCAT; 3’ primer GGACTGCAGCGTAGACG
CTT) were added, and product amplification was mea-
sured with an ABI HT7900 Fast Real-Time PCR System.
The threshold cycle (Ct) was obtained from duplicate sam-
ples and averaged. The ΔCt was the difference between
the average Ct for influenza and HPRT. The ΔΔCt was the
ΔCt of the Mmp28
-/- samples minus the average ΔCt of
matched wild-type samples. The data are expressed as
relative quantification (RQ), which is the fold change and
calculated as 2
-ΔΔCt.
Statistics
Results are expressed as means ± SEM. Statistic signifi-
cance was determined using the Student’s t test. Differ-
ences were considered significant if the p value was < 0.05.
Results
Generation of Stable Cell Lines
To establish stable cell lines over-expressing wild-type
or mutant MMP28, we transfected A549 and BEAS-2B
cells with plasmids containing full-length wild-type
(wtMMP28-V5) or catalytically-inactive (mutMMP28-
V5) MMP28. Each construct was tagged with a V5 epi-
tope on the carboxy terminus, and the mutant construct
was engineered with a single amino-acid change within
the catalytic-domain, rendering it inactive as previously
reported [15]. Transfected cells were selected for anti-
biotic resistance with Geneticin, and two wild-type
clones and two mutant clones were identified as expres-
sers of MMP28 using immunostaining with commer-
cially-available V5 antibodies (Figure 1A). We also
identified cells that expressed no recombinant MMP28
(A549 neg) but were maintained under the same culture
conditions (data not shown).
In both cell lysates and supernatant from the mutant
and wild-type clones, we identified both the zymogen
(proMMP28; 58 kD) and the furin-cleaved (MMP28;
48 kD) forms of the enzyme (Figure 1B). As expected,
most of the protein in the supernatant was the 48-kD acti-
vated enzyme (of course, the E-A mutant form does not
gain activity after the prodomain is cleaved). In addition to
its diffuse cytoplasmic and peri-Golgi staining, MMP28
localized to the cell membrane as described by others [15].
However, in contrast to previous findings [15], we found
no change in the morphology of cells expressing wild-type
(or mutant) MMP28. Furthermore, the ability of cells to
adhere to type I collagen or to close scrape wounds [17]
was not influenced by expression of wildtype or mutant
MMP28 (data not shown).
MMP-28 Promotes Cell Survival
We observed that A549 cells expressing wild-type MMP28
had increased survival rates during serum-deprivation
compared to cells expressing mutant or no MMP28. After
6 days in serum-free medium, only wild-type clones
remained viable (Figure 2A). Assessment of nuclear con-
densation, one morphologic change associated with apop-
tosis, using DAPI staining at 24 h after serum deprivation,
demonstrated increased condensed nuclei in A549 neg and
muMMP28 cells when compared to wtMMP28 cells (Fig-
ure 2B). To explore these observations further, we induced
apoptosis in cells with increasing doses of staurosporine
and assessed caspase 3/7 activity 16 h later. At all doses of
staurosporine, we observed less caspase 3/7 activity in cells
expressing wtMMP28-V5 compared to cells expressing cat-
alytically inactive MMP28 (Figure 3A). These findings were
confirmed in other experiments in which cells were treated
with increasing doses of staurosporine for 16 h and cell via-
bility was measured with Alamar Blue (Figure 3B). A549
neg cells, expressing no recombinant MMP28 protein,
behaved similar to muMMP28 clones (data not shown).
Together, these results indicate that active MMP28 pro-
motes epithelial cell survival.
To assess if this survival effect was mediated in other
epithelial cells, we examined if MMP28 could confer
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2B cells, a human pulmonary epithelial cell line. Stable
cell lines were created using wild-type and mutant
human MMP28, and two positive clones of each were
assessed for their ability to resist apoptosis using a cas-
pase 3/7 activity assay. As seen with A549 cells, we
observed less staurosporine-induced caspase 3 activity in
BEAS-2B cells expressing wtMMP28-V5 compared to
mutant-expressing cells (Figure 3C). However, this pro-
tective effect of wild-type MMP28 was seen at the low-
est doses of staurosporine (0.062 and 0.125 μM). At
higher doses, BEAS-2B cells were overall more sensitive
to staurosporine-induced apoptosis than were A549
cells. We also observed increased caspase 3/7 activity in
the mutant cells in the no staurosporine (0 μM) group,
likely reflecting differences in apoptosis induced by
serum-deprivation.
Mmp28
-/- Mice have increased airway epithelial cell
apoptosis
To examine if MMP28 influences cell survival in vivo, we
tested the Mmp28
-/- mice for increased susceptibility to
airway epithelial apoptosis. Because influenza infection
targets the airway epithelium and leads to epithelial cell
Figure 1 Representative images demonstrating expression of recombinant, V5-tagged wild-type and mutant MMP28 in A549 cells.A .
Immunofluorescence (IF) using FITC-conjugated anti-V5 antibody. Bottom right image demonstrates localization of MMP28 to the plasma
membrane. B. Western blot (WB) of supernatants (S) and cell lysates (L) from representative mutant and wild-type clones. Membranes were
stained with anti-V5 HRP. The larger band (58 kDa) represents the pro-form, which is more abundant in the cell lysate, and the smaller band (48
kDa) represents the secreted active form, which is more abundant in the supernatant. A549 cells had no staining by IF or WB using the V5
antibodies.
Figure 2 Over-expression of wild-type MMP28 confers a cell-survival advantage during serum-deprivation conditions. An equal number
of A549 neg, wtMMP28 and muMMP28 cells (1-2 clones each, performed in duplicate) were plated onto collagen I-coated chamber slides in the
absence of serum. (A) After 6 days in culture, the above images were obtained demonstrated floating cellular debris in the A549 neg and
mutant clones (left 3 columns) and many viable cells in the wild-type clones (right 2 columns). Notably, initial adherence and spreading of the
cells on collagen were similar, but survival after six-days of serum-deprivation was enhanced in clones expressing active MMP28. (B) Assessment
of nuclear condensation and fragmentation (associated with apoptosis) using DAPI staining of serum-deprived cells at 24 h, revealed increased
condensed (arrows) and fragmented (arrowhead) nuclei in only the A549 neg, muMMP28 cells and not wtMMP28.
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Page 4 of 9Figure 3 Expression of wild-type MMP-28 protects against staurosporine-induced apoptosis in A549 and BEAS-2B cells. A549 (A, B) or
BEAS-2B (C) cells expressing wild-type MMP-28 (closed circle) or mutant MMP-28 (open circle) were plated on a 96-well plate with increasing
doses of staurosporine in serum-free medium (0 - 2 μM). After 16 h incubation with staurosporine or serum-free medium, the level of caspase 3/
7 activity was determined by measuring the fluorescence of a cleaved caspase 3/7 substrate (A,C). In separate experiments, the cell viability was
assessed by Alamar Blue staining (B).
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increased apoptosis in Mmp28
-/- epithelium. Age and sex
matched Mmp28
-/- and wild-type mice were infected
with murine influenza strain A/PR/8/34 at 100 PFU/
mouse. On day 3 and 5 post-infection, caspase 3/7 activ-
ity was measured in homogenates of the left lungs. We
found that Mmp28
-/- mice had a significant increase
(68.3 ± 7.65%; p < 0.0006) in whole lung caspase 3/7
activity compared to the level detected in wild-type
h o m o g e n a t e sa td a y3( F i g u r e4 B )b u tn o ta td a y5( n o t
shown). In the same experiment, the right lung was col-
lected and processed for immunostaining with an anti-
active caspase 3 antibody. In both wild-type and
Mmp28
-/- mice, most (>95%) caspase 3 activity localized
to the airway epithelium at day 3 (Figure 4B). At day 0
(uninfected), there was no difference in caspase 3/7 activ-
ity between genotypes and there was markedly less active
caspase 3 staining in the airway compared to day 3
(Figure 4A, C).
Since airway epithelial apoptosis has been proposed as a
mechanism for viral clearance [21], we hypothesized that
increased apoptosis in the Mmp28
-/- mice would result in
faster viral clearance. Viral levels were assessed by using
real-time PCR of the viral genome sequences at days 0, 3,
5, and 7 days post-infection. Despite differences in epithe-
lial cell apoptosis at 3 days, we found that influenza virus
levels were similar at all time-points in Mmp28
-/- and
wild-type mice, suggesting that MMP28 is not required
for control of influenza infection (Figure 5B). Furthermore,
we found that MMP28 mRNA expression from influenza-
challenged whole lung was unchanged in early infection
(days 1-2) and decreased at later timepoints (days 3-5), in
contrast to other MMPs -3,-7,-12 (Figure 5A). This down-
regulation of MMP28 by epithelial cells has been seen in
other pulmonary infection models[12], and may be one
mechanism by which host epithelial cells respond to infec-
tion. Furthermore, this delay in MMP28 down-regulation
may explain our findings of differences in caspase 3/7
activity at day 3 but not day 5.
Discussion
The respiratory epithelium in the lung has adapted to
continuous environmental exposures and pathogenic sti-
muli. It serves to protect the host from organisms
through barrier function, mechanical clearance, secretion
of inhibitors of bacterial growth, and release of chemo-
kines and other factors to recruit and activate leukocytes.
Given the constant environmental exposures challenging
the epithelium, mechanisms have evolved to restrain
inflammatory responses and promote epithelial survival.
Our studies suggest that constitutive expression of
epithelial MMP28 contributes to this latter process.
Our studies demonstrate a novel role for MMP28 in
promoting epithelial cell survival. Both in vitro and in
vivo studies indicate that MMP28 promotes airway
epithelial cell survival when challenged by virus, serum-
deprivation, or staurosporine. These studies provide
some insight as to potential evolutionary pressures that
have resulted in epithelial cell down-regulation of
MMP28 during infection as a potential mechanism to
facilitate apoptosis of injured or infected epithelium.
Although other groups have reported that influenza
infection is a potent inducer of epithelial cell apoptosis
[18-20], one limitation of our in vivo studies is that
caspase 3/7 activity may also regulate non-apoptotic path-
ways. Another limitation of our study is that A549 cells,
which are tumor-derived alveolar epithelial cells, and
BEAS-2B cells, which are immortalized human bronchial
epithelial cells, have altered survival and apoptotic path-
ways that differ from normal. Hence, our findings will
need to be confirmed in primary epithelial cells as well.
However, these studies highlight another potential role for
MMP28 in cancer cell biology, as MMP28 expression has
been associated with several malignancies [22,23]. In our
studies of Mmp28
-/- and wild-type mice crossed with
K-ras
LA1 mutant, we found a significant decrease in spon-
taneous lung tumor formation in the Mmp28
-/- mice com-
pared to wild-type mice (unpublished findings). Although
we have not yet linked these findings to differences to
apoptosis, potentially, the presence of MMP28 may confer
a survival advantage leading to more lung tumors in this
model.
The mechanism by which MMP28 contributes to cell
survival remains unknown. Since MMP28 localizes to the
cell membrane, it is likely that its substrate resides in close
proximity and may be a receptor or other membrane-asso-
ciated protein that participates in cell survival pathways.
Such factors include growth factors (EGF/IGF-1/TGFa)
and their receptors which signal through PI3K, Ras or
JAK-STAT pathways to upregulate gene transcription of
factors that promote cell survival [24].
Other metalloproteases function in regulating apopto-
tic and anti-apoptotic pathways. For example, TACE/
ADAM17 is responsible for shedding of the pro-tumor
necrosis factor (proTNF-a)[ 2 5 ] .F u r t h e r m o r e ,i ti sa l s o
necessary for shedding of the EGF family of growth fac-
tors [26], which function in cell survival pathways.
MMP7 mediates apoptosis via cleavage of FasL, making
cells more resistant to apoptosis [27]. Cleavage of death
domain receptors (such as FAS) or inactivation of their
ligands could interfere with these specific apoptotic path-
ways, but are unlikely mechanisms in MMP28 mediated
cell survival since the challenges used to induce apoptosis
(serum deprivation, staurosporine and viral infection) do
not share these pathways; however, roles of MMP28 in
shedding of growth factors remains unknown.
Interestingly, we did not observe any features of an
epithelial-to-mesenchymal transformation (EMT), such
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-/- Mice. C57BL/6 wild-type mice and
Mmp28
-/- mice received 100 PFU of mouse-adapted H1N1 influenza (A/PR/8/34) via oropharyngeal aspiration. At days 3 and 5 post-infection, the
left lung was homogenized for caspase 3/7 activity, and the right lung was processed for immunohistochemistry using rabbit anti-cleaved
(active) caspase 3 antibody, and anti-rabbit IgG conjugated to Alexa 568. (A) At day 0, there was similar background caspase 3/7 activity in the
lungs from wild-type and Mmp28-/- mice. (B) At day 3, there was increased caspase 3/7 activity in Mmp28
-/- lungs, and (C) this activity localized
to the bronchial epithelium at day 3. There was no significant caspase staining in the airways at day 0 in either genotype. (n = 4-5 mice/
genotype/timepoint). *p value < 0.05
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or migration, in MMP28 over-expressing cell lines, as
reported by others [15]. However, resistance to apopto-
sis is a property of EMT [28-30], and we may have
observed an “intermediate” phenotype in our studies.
Differences between our phenotypes and those reported
by others may relate to the relative abundance of
MMP28 expression due to promoter and vector differ-
ences, or differences in the cell lines[31]. However, since
MMP28 is constitutively expressed in epithelial cells, it
Figure 5 MMP28 expression in the lung decreases in influenza infection and does not contribute to viral replication or clearance.
C57BL/6 wild-type and Mmp28
-/- mice were infected with 100 PFU of mouse-adapted H1N1 influenza (A/PR/8/34), and the lungs were harvested
at serial time-points for RNA isolation. (A) Expression of MMPs -3,-7,-12, and -28 was assessed using real-time PCR. Only MMP28, which is
constitutively expressed in the naïve lung, decreased during infection. (n = 4 mice/time-point). P value <0.05 for all MMPs when compared to
their respective baseline expression at D0, except for MMP7 at D4. (B) Viral titers as assessed by RT-PCR from lung homogenates did not differ
between wild-type and Mmp28
-/- mice (n = 4-5 mice of each genotype/time-point).
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transformation in vivo. We propose that MMP28 func-
tions normally to resist apoptosis, and indeed, the
enhanced cell death we observed in virally infected
Mmp28
-/- mice supports this conclusion. Ongoing stu-
dies are aimed at determining the mechanism by which
MMP28 promotes cell survival.
Conclusion
MMP28 is constitutively expressed by the respiratory
epithelium, suggesting roles in maintaining homeostasis.
We have found that expression of catalytically-active
MMP28 in lung epithelial cells promotes cell survival.
Furthermore, Mmp28-/- mice demonstrate increased sus-
ceptibility to influenza-induced respiratory epithelial cell
apoptosis. These studies ide n t i f yap r e v i o u s l yu n k n o w n
role for MMP28 in respiratory cell biology.
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